Intense multidisciplinary research has provided detailed knowledge of the molecular pathogenesis
of Alzheimer disease (AD). This knowledge has been translated into new therapeutic …

Background Alzheimer's disease biomarkers are important for early diagnosis in routine
clinical practice and research. Three core CSF biomarkers for the diagnosis of Alzheimer's …

Mild traumatic brain injury (TBI), which is defined as a head trauma resulting in a brief loss of
consciousness and/or alteration of mental state, is usually benign, but occasionally causes …

Context Small single-center studies have shown that cerebrospinal fluid (CSF) biomarkers
may be useful to identify incipient Alzheimer disease (AD) in patients with mild cognitive …

… Author Contributions: Drs Zetterberg and Skillbäck contributed equally to this work. Dr
Zetterberg had full access to all the data in the study and takes responsibility for the integrity of the …

Background Disease-modifying treatment strategies for Alzheimer's disease have led to an
urgent need for biomarkers to identify the disease at a very early stage. Here, we assess the …

Background We used a sensitive and specific β-site amyloid precursor protein (APP)–cleaving
enzyme 1 (BACE1) assay to determine the relationship between BACE1 activity in …

Importance Cerebral amyloid-β aggregation is an early pathological event in Alzheimer
disease (AD), starting decades before dementia onset. Estimates of the prevalence of amyloid …

Clinical trial results presented in 2019 suggest that antibody-based removal of cerebral
amyloid β (Aβ) plaques may possibly clear tau tangles and modestly slow cognitive decline in …

Background Little solid information is available on the possible risks for neuronal injury in
amateur boxing. Objective To determine whether amateur boxing and severity of hits are …